ESTHMR إستثمر

Ibnsina Pharma ISPH

ابن سينا فارما

Health Care & PharmaceuticalsEgyptian Exchange

11.70 EGP

+1.74%

Close of Thu 1 Oct 2026

Market value
EGP 11.79bn
Highest and lowest close in a year
9.70 – 14.55
Shares traded in the session
10,439,748
Open the full company record in ESTHMR

A chart of every session, the financial statements, the nine checks and filing alerts. Free, with your e-mail and a six-digit code.

About the company

Ibnsina Pharma is a Cairo-based pharmaceutical company operating in the pharmaceuticals, biotechnology, and life sciences sector. Established in December 2000 and incorporated on 18 December 2000, it has been listed on the EGX since November 2017. Faisal Islamic Bank of Egypt holds 13.99%, alongside individual and institutional shareholders. The company owns a 99.99% stake in AIM for Investment and Consulting in Healthcare.

Facts from Mubasher

Its record at the exchange

Across 527 filings between 2017 and 2026, Ibnsina Pharma's busiest year was 2022 with 141 filings. Trading was suspended and resumed 3 times. Across 47 reported periods, the company recorded zero loss-making periods, with net profit ranging from 28 million EGP in Q1 2018 to a peak of 660 million EGP in 9M 2025. Filings include 86 board decisions, 81 assembly meetings, and 5 bonus share disclosures.

Its latest filings at the exchange

  1. Shareholders' meetingIbn Sina Pharma (ISPH.CA) - Summary of Extraordinary General Assembly resolutions
  2. StatementStatement from Ibn Sina Pharma (ISPH.CA) regarding its regulatory framework
  3. Shareholders' meetingIbn Sina Pharma (ISPH.CA) - Minutes of the Ordinary General Assembly Meeting (Notarized)
  4. Shareholders' meetingIbn Sina Pharma (ISPH.CA) - Summary of Ordinary General Assembly Resolutions
  5. Shareholders' meetingStatement from Ibn Sina Pharma (ISPH.CA) regarding the call for the Extraordinary General Assembly
  6. Shareholders' meetingIbn Sina Pharma (ISPH.CA) - Summary of Extraordinary General Assembly resolutions

Insider trades in the exchange’s bulletin

As the exchange publishes them in each session’s bulletin: the trader’s capacity, not their name. Each row opens the bulletin itself.

  1. Insider / Board Bought20,000 (less than 0.01% of the company)Bulletin ↗
  2. Insider / Board Bought18,000 (less than 0.01% of the company)Bulletin ↗
  3. Insider / Board Sold40,000 (less than 0.01% of the company)Bulletin ↗
  4. Connected Group Sold50,000 (less than 0.01% of the company)Bulletin ↗
  5. Insider / Board Bought20,616 (less than 0.01% of the company)Bulletin ↗
  6. Insider / Board Sold941,527 (0.09% of the company)Bulletin ↗
  7. Insider / Board Bought300,000 (0.03% of the company)Bulletin ↗
  8. Insider / Board Sold499,969 (0.05% of the company)Bulletin ↗
  9. Insider / Board Bought40,000 (less than 0.01% of the company)Bulletin ↗
  10. Insider / Board Bought40,000 (less than 0.01% of the company)Bulletin ↗

Other companies in Health Care & Pharmaceuticals

Page updated with the data of 1 Oct 2026.